CTLA4 and neoplasm: To test if anti-CTLA-4 antibody treatment increased the efficacy of the immunisation regimen, anti-CTLA-4 or an isotype control antibodies were administered to mice with pre-existing tumours on the same day as the primary vaccination, then twice more at two day intervals (Fig 5a).